Risk Factors Associated with Juvenile Idiopathic Arthritis: Exposure to Cigarette Smoke and Air Pollution from Pregnancy to Disease Diagnosis

Carregando...
Imagem de Miniatura
Citações na Scopus
18
Tipo de produção
article
Data de publicação
2018
Editora
J RHEUMATOL PUBL CO
Indexadores
Título da Revista
ISSN da Revista
Título do Volume
Autor de Grupo de pesquisa
Editores
Coordenadores
Organizadores
Citação
JOURNAL OF RHEUMATOLOGY, v.45, n.2, p.248-256, 2018
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Objective. To evaluate exposure to environmental factors inhaled during pregnancy and after birth until juvenile idiopathic arthritis (JIA) diagnosis among residents of a large city. Methods. This is an exploratory case-control study that consists of 66 patients with JIA and 124 healthy controls matched by age and sex, living in the Sao Paulo, Brazil, metropolitan area until JIA diagnosis, and whose mothers had resided in this region during pregnancy. A structured and reliable questionnaire (k index for test-retest was 0.80) assessed demographic data, gestational and perinatal-related factors, and exposure to inhalable environmental elements during pregnancy and after birth (occupational exposure to inhalable particles and/or volatile vapor, exposure to cigarette smoke, and the presence of industrial activities or gas stations near the home, work, daycare, or school). Tropospheric pollutants included particulate matter (PM10), sulfur dioxide (SO2), nitrogen dioxide (NO2), ozone (O-3), and carbon monoxide (CO). Results. During pregnancy, intrauterine cigarette smoke exposure (OR 3.43, 95% CI 1.45-8.12, p = 0.005) and maternal occupational exposure (OR 13.69, 95% CI 4.4-42.3, p < 0.001) were significant independent risk factors for JIA diagnosis. In contrast, maternal employment (OR 0.06, 95% CI 0.02-0.2, p < 0.001) and ideal maternal weight gain (OR 0.36, 95% CI 0.2-0.8, p = 0.017) presented negative associations. Secondhand smoke exposure from birth to JIA diagnosis (OR 3.6, 95% CI 1.8-7.3, p < 0.001) and exposure to O-3 during the second year of life (OR 2.76, 95% CI 1.20-6.37, p = 0.017) were independent and significant risk factors for the pathogenesis of JIA. Conclusion. In our study, cigarette smoke exposure (intrauterine and after birth), exposure to O-3 in the second year of life, and maternal occupational exposure were identified as potential risk factors for JIA, warranting further study.
Palavras-chave
JUVENILE IDIOPATHIC ARTHRITIS, ENVIRONMENTAL FACTOR, SMOKING, AIR POLLUTION, MATERNAL OCCUPATIONAL EXPOSURE
Referências
  1. ABEP, 2013, CRIT PADR CLASS EC B
  2. Afridi HI, 2014, CLIN LAB, V60, P1735, DOI 10.7754/Clin.Lab.2014.131117
  3. Anderson R, 2016, NICOTINE TOB RES, V18, P1556, DOI 10.1093/ntr/ntw030
  4. Apte K, 2016, F1000RES, V5
  5. Bernatsky S, 2016, ENVIRON RES, V146, P85, DOI 10.1016/j.envres.2015.12.021
  6. Breton CV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099716
  7. Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1
  8. Calderon-Garciduenas L, 2008, INHAL TOXICOL, V20, P499, DOI [10.1080/08958370701864797, 10.1080/08958370701864797 ]
  9. Centers for Disease Control and Prevention (CDC), ALC US YOUR HLTH
  10. CETESB, RED MON
  11. Chang KH, 2016, ENVIRON INT, V94, P495, DOI 10.1016/j.envint.2016.06.008
  12. Chuang GC, 2009, AM J PHYSIOL-LUNG C, V297, pL209, DOI 10.1152/ajplung.00102.2009
  13. De Roos AJ, 2014, ENVIRON HEALTH PERSP, V122, P1075, DOI 10.1289/ehp.1307413
  14. Di Giuseppe D, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4498
  15. Ellis JA, 2012, PEDIATR RHEUMATOL, V10, DOI 10.1186/1546-0096-10-37
  16. Elvidge T, 2013, J ENVIRON SCI HEAL C, V31, P1, DOI 10.1080/10590501.2013.763575
  17. Farhat J, 2016, REV BRAS REUMATOL, V56, P212, DOI 10.1016/j.rbre.2015.08.005
  18. Farhat SCL, 2011, AUTOIMMUN REV, V11, P14, DOI 10.1016/j.autrev.2011.06.008
  19. Fernandes EC, 2015, ARTHRIT CARE RES, V67, P1609, DOI 10.1002/acr.22603
  20. Goodman JE, 2015, CRIT REV TOXICOL, V45, P412, DOI 10.3109/10408444.2015.1031371
  21. Gryparis A, 2004, AM J RESP CRIT CARE, V170, P1080, DOI 10.1164/rccm.200403-333OC
  22. Guimarães Mariana Tavares, 2011, Rev. bras. epidemiol., V14, P598, DOI 10.1590/S1415-790X2011000400007
  23. Hart JE, 2013, ARTHRIT CARE RES, V65, P1190, DOI 10.1002/acr.21975
  24. Hart JE, 2013, ANN RHEUM DIS, V72, P888, DOI 10.1136/annrheumdis-2012-201587
  25. Hart JE, 2009, ENVIRON HEALTH PERSP, V117, P1065, DOI 10.1289/ehp.0800503
  26. Jaakkola JJ, 2005, INT J EPIDEMIOL, V34, P664, DOI 10.1093/ije/dyi006
  27. Joubert BR, 2012, ENVIRON HEALTH PERSP, V120, P1425, DOI 10.1289/ehp.1205412
  28. Karlson EW, 1999, ARTHRITIS RHEUM, V42, P910, DOI 10.1002/1529-0131(199905)42:5<910::AID-ANR9>3.3.CO;2-4
  29. Knopik VS, 2012, DEV PSYCHOPATHOL, V24, P1377, DOI 10.1017/S0954579412000776
  30. Lee KWK, 2015, ENVIRON HEALTH PERSP, V123, P193, DOI 10.1289/ehp.1408614
  31. Miligi L, 2013, OCCUP ENVIRON MED, V70, P648, DOI 10.1136/oemed-2012-100951
  32. Morales E, 2016, INT J EPIDEMIOL, V45, P1644, DOI 10.1093/ije/dyw196
  33. The National Academies Press, 2009, WEIGHT GAIN PREGNANC
  34. Orione MAM, 2014, ARTHRIT CARE RES, V66, P1571, DOI 10.1002/acr.22358
  35. Perez-Padilla R, 2010, INT J TUBERC LUNG D, V14, P1079
  36. Petty RE, 2004, J RHEUMATOL, V31, P390
  37. Shea AK, 2008, NICOTINE TOB RES, V10, P267, DOI 10.1080/14622200701825908
  38. Shenoi S, 2016, ARTHRIT CARE RES, V68, P1186, DOI 10.1002/acr.22806
  39. Shenoi S, 2015, ARTHRIT CARE RES, V67, P725, DOI 10.1002/acr.22471
  40. Silva Clovis Artur A., 2004, J. Pediatr. (Rio J.), V80, P517, DOI 10.1590/S0021-75572004000800015
  41. Stolt P, 2005, ANN RHEUM DIS, V64, P582, DOI 10.1136/ard.2004.022053
  42. Sugiyama D, 2010, ANN RHEUM DIS, V69, P70, DOI 10.1136/ard.2008.096487
  43. Vidotto JP, 2012, LUPUS, V21, P526, DOI 10.1177/0961203312437806
  44. Watkinson WP, 2001, ENVIRON HEALTH PERSP, V109, P539, DOI 10.2307/3454666
  45. WHO, 2016, AMB AIR POLL GLOB AS
  46. Yamashita E, 2013, REV BRAS REUMATOL, V53, P542, DOI [10.1016/j.rbre.2013.04.005, 10.1016/j.rbr.2013.04.005]
  47. Zeft AS, 2016, CLIN EXP RHEUMATOL, V34, P946
  48. Zeft AS, 2009, CLIN EXP RHEUMATOL, V27, P877
  49. Zhou YF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110466